The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

By J. Wedzicha, P. Calverley, T. Seemungal, G. Hagan, Z. Ansari, R. Stockley. American Journal of Respiratory and Critical Care Medicine, 2008

882 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/d922e824f6c493357abe8e0e2648edfca96a13c4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. P. Barnes
2. P. Calverley

In Pulmonary and Respiratory Medicine

1. P. Barnes
2. R. Rodríguez-Roisín
3. C. Jenkins
4. Sonia Buist
5. Jan Zieliński
6. Yoshinosuke Fukuchi
7. S. Hurd
8. A. Anzueto

Citations in the corpus

• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “К сожале! нию, только в одном исследовании проводилось прямое сравнение указанных комбинаций, что усложняет их со! поставление [389].”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “Unfortunately, there is only one study directly comparing these treatments, which makes differentiation difficult (80).”